Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer.
Sella T, Gelber SI, Poorvu PD, Kim HJ, Dominici L, Guzman-Arocho YD, Collins L, Ruddy KJ, Tamimi RM, Peppercorn JM, Schapira L, Borges VF, Come SE, Warner E, Snow C, Jakubowski DM, Russell CA, Winer EP, Rosenberg SM, Partridge AH. Sella T, et al. Among authors: russell ca. Breast Cancer Res Treat. 2021 Feb;186(1):157-165. doi: 10.1007/s10549-020-05989-5. Epub 2020 Nov 4. Breast Cancer Res Treat. 2021. PMID: 33150547
Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer.
Poorvu PD, Gelber SI, Rosenberg SM, Ruddy KJ, Tamimi RM, Collins LC, Peppercorn J, Schapira L, Borges VF, Come SE, Warner E, Jakubowski DM, Russell C, Winer EP, Partridge AH. Poorvu PD, et al. J Clin Oncol. 2020 Mar 1;38(7):725-733. doi: 10.1200/JCO.19.01959. Epub 2019 Dec 6. J Clin Oncol. 2020. PMID: 31809240 Free PMC article.
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.
Ma CX, Bose R, Gao F, Freedman RA, Telli ML, Kimmick G, Winer E, Naughton M, Goetz MP, Russell C, Tripathy D, Cobleigh M, Forero A, Pluard TJ, Anders C, Niravath PA, Thomas S, Anderson J, Bumb C, Banks KC, Lanman RB, Bryce R, Lalani AS, Pfeifer J, Hayes DF, Pegram M, Blackwell K, Bedard PL, Al-Kateb H, Ellis MJC. Ma CX, et al. Clin Cancer Res. 2017 Oct 1;23(19):5687-5695. doi: 10.1158/1078-0432.CCR-17-0900. Epub 2017 Jul 5. Clin Cancer Res. 2017. PMID: 28679771 Free PMC article. Clinical Trial.
Lymph node status in inflammatory breast cancer.
Wecsler JS, Tereffe W, Pedersen RC, Sieffert MR, Mack WJ, Cui H, Russell CA, Woods RR, Viscusi RK, Sener SF, Lang JE. Wecsler JS, et al. Among authors: russell ca. Breast Cancer Res Treat. 2015 May;151(1):113-20. doi: 10.1007/s10549-015-3367-6. Epub 2015 Apr 7. Breast Cancer Res Treat. 2015. PMID: 25846421 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 35902504
A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.
Lyman GH, Green SJ, Ravdin PM, Geyer CE Jr, Russell CA, Balcerzak SP, Thomas Budd G, Martino S; Southwest Oncology Group Randomized Phase II Study. Lyman GH, et al. Among authors: russell ca. Breast Cancer Res Treat. 2004 May;85(2):143-50. doi: 10.1023/B:BREA.0000025405.63953.f9. Breast Cancer Res Treat. 2004. PMID: 15111772 Clinical Trial.
Young-Onset Colon Cancer and Recurrence Risk by Gene Expression.
Chang GJ, You YNY, Russell CA, Tierno MB, Turner M, Bennett JP, Lau A, Hochster HS. Chang GJ, et al. Among authors: russell ca. J Natl Cancer Inst. 2020 Nov 1;112(11):1170-1173. doi: 10.1093/jnci/djaa019. J Natl Cancer Inst. 2020. PMID: 32040172 Free PMC article.
290 results